• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Ozempic (semaglutide)

European Medicines Agency
Pharma

'Sharp rise' in illegal obesity drugs, Europe warns

European regulators are warning again about the sale of counterfeit versions of Novo Nordisk’s and Eli Lilly’s popular weight loss drugs.
Kevin Dunleavy Sep 5, 2025 11:16am
Teva Pharmaceuticals

Teva launches first generic version of Novo's GLP-1 Saxenda

Aug 28, 2025 3:45pm
Novo Nordisk Ozempic semaglutide

Novo Nordisk unveils $499 cash-pay Ozempic offering

Aug 18, 2025 11:01am
Novo Nordisk

Novo's new CEO takes over at difficult time for drugmaker

Aug 6, 2025 11:43am
Ozempic Wegovy

Novo faces lawsuit over semaglutide sales projections

Aug 5, 2025 8:30am
Mounjaro tirzepatide

Mounjaro measures up to Trulicity in Eli Lilly cardio trial

Jul 31, 2025 8:12am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings